Hepatic inflammation elicits production of proinflammatory netrin‐1 through exclusive activation of translation
Authors:
- Romain BarnaultRBRomain Barnault
- Claire VerzeroliCVClaire Verzeroli
- Carole FournierCFCarole Fournier
- Maud MicheletMMMaud Michelet
- Anna Rita RedavidARAnna Rita Redavid
- Ievgeniia ChicherovaICIevgeniia Chicherova
- Marie‐Laure PlissonnierMPMarie‐Laure Plissonnier
- Annie AdraitAAAnnie Adrait
- Olga KhomichOKOlga Khomich
- Fleur ChapusFCFleur Chapus
- Mathieu RichaudMRMathieu Richaud
- 1 April 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 76 (5) , 1345-1359
Abstract
Background and Aims: Netrin‐1 displays protumoral properties, though the pathological contexts and processes involved in its induction remain understudied. The liver is a major model of inflammation‐associated cancer development, leading to HCC. Approach and Results: A panel of cell biology and biochemistry approaches (reverse transcription quantitative polymerase chain reaction, reporter assays, run‐on, polysome fractionation, cross linking immunoprecipitation, filter binding assay, subcellular fractionation, western blotting, immunoprecipitation, stable isotope labeling by amino acids in cell culture) on in vitro–grown primary hepatocytes, human liver cell lines, mouse samples and clinical samples was used. We identify netrin‐1 as a hepatic inflammation‐inducible factor and decipher its mode of activation through an exhaustive eliminative approach. We show that netrin‐1 up‐regulation relies on a hitherto unknown mode of induction, namely its exclusive translational activation. This process includes the transfer of NTN1 (netrin‐1) mRNA to the endoplasmic reticulum and the direct interaction between the Staufen‐1 protein and this transcript as well as netrin‐1 mobilization from its cell‐bound form. Finally, we explore the impact of a phase 2 clinical trial‐tested humanized anti‐netrin‐1 antibody (NP137) in two distinct, toll‐like receptor (TLR) 2/TLR3/TLR6‐dependent, hepatic inflammatory mouse settings. We observe a clear anti‐inflammatory activity indicating the proinflammatory impact of netrin‐1 on several chemokines and Ly6C+ macrophages. Conclusions: These results identify netrin‐1 as an inflammation‐inducible factor in the liver through an atypical mechanism as well as its contribution to hepatic inflammation.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR‐10‐INBS‐08, ANR‐17‐EURE‐0003, ANR‐LABX‐061)
- Institut National Du Cancer (PRT‐K19‐033)
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ63958)
This publication has 42 references indexed in Scilit:
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaquesNature Immunology, 2012
- Hierarchical regulation of mRNA partitioning between the cytoplasm and the endoplasmic reticulum of mammalian cellsMolecular Biology of the Cell, 2011
- Mechanisms of hepatic fibrogenesisBest Practice & Research Clinical Gastroenterology, 2011
- The Dependence Receptor UNC5H2/B Triggers Apoptosis via PP2A-Mediated Dephosphorylation of DAP KinaseMolecular Cell, 2010
- Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progressionProceedings of the National Academy of Sciences, 2009
- NF-κB Regulates Netrin-1 Expression and Affects the Conditional Tumor Suppressive Activity of the Netrin-1 ReceptorsGastroenterology, 2008
- Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNANature, 2008
- Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancerProceedings of the National Academy of Sciences, 2008
- The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6Cell, 1994